Bio Skylife Private Limited
About Bio Skylife Private Limited
Data last updated:
Bio Skylife Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52520DL2021PTC380495. Its GSTIN is 07AAJCB8160E1ZP (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajroop and Mukeem Sabir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1205 – D Mall Netaji Subhash Place, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.9 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹5.21 Lakh (net margin 0.6%) and EBITDA of ₹7.04 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 639% over three years.
Company details
Contact details
Bio Skylife Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1205 – D Mall Netaji Subhash Place, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Bio Skylife Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bio Skylife is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Bio Skylife Private Limited, buy the company report.
Financials of Bio Skylife Private Limited
FY 2025 filings availableBio Skylife Private Limited reported revenue of ₹8.9 Cr (down 33% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 33% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 639%. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹7.04 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.21 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.8% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Bio Skylife Private Limited, buy the company report.
Board of directors of Bio Skylife Private Limited
Bio Skylife has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajroop | Director | 22 Apr 2021 | 5 Years 6 Months | Current |
| Mukeem Sabir | Director | 22 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Bio Skylife Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innovations Mediresearch Private Limited | ₹9.03 Cr (FY 2025) | -5.0% | Jaipur, Rajasthan, India | |||
| Ved Hospital Superspeciality & Medical Research Private Limited | ₹9 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Neshlin Medtech Private Limited | ₹9 Cr (FY 2025) | 818.0% | Bhopal, Madhya Pradesh, India | |||
| JDC Healthcare & Diagnostic Private Limited | ₹8.97 Cr (FY 2025) | 9.0% | Sonipat, Haryana, India | |||
| Bharat Health & Wellness Private Limited | ₹8.94 Cr (FY 2025) | 10936.0% | Delhi, India | |||
| Bio Skylife Private Limitedthis company | ₹8.9 Cr (FY 2025) | ₹5.21 Lakh | 0.6% | -33.0% | Delhi, India | |
| SPJ Onco Care Private Limited | ₹8.88 Cr (FY 2025) | -8.0% | Mumbai, Maharashtra, India | |||
| Vida Lifesciences Private Limited | ₹8.84 Cr (FY 2025) | 33.0% | Pune, Maharashtra, India | |||
| Pachouli Aesthetics and Wellness Private Limited | ₹8.76 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India | |||
| Patna Orthopaedic and Multispeciality Hospital Private Limited | ₹8.7 Cr (FY 2025) | 49.0% | Assam, India | |||
| Nextcare Hospital Private Limited | ₹8.69 Cr (FY 2025) | 1349.0% | Himatnagar, Gujarat, India |
To see the full peer comparison of Bio Skylife Private Limited, buy the company report.
Auditor
Bio Skylife Private Limited is audited by C N S & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C N S & Co. | FY 2022 | 018215C |
Shareholding
The shareholding of Bio Skylife Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bio Skylife Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bio Skylife Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bio Skylife Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bio Skylife Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
GST
Bio Skylife has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCB8160E1ZP | Delhi | Active | 02 Jul 2021 |
To see the full GST registrations and return filing status of Bio Skylife Private Limited, buy the company report.
Recent activity
Bio Skylife Private Limited has 5 board changes on record since 2021: 3 appointments and 2 cessations. The latest: Aman Singh Bhandari ceased to be Director on 23 Sep 2025.
Frequently asked questions
Bio Skylife is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 April 2021 (5+ years old) and is registered under CIN U52520DL2021PTC380495.
Bio Skylife has 2 current directors:
- Rajroop - Director
- Mukeem Sabir - Director
The latest financial statements of Bio Skylife on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Bio Skylife is 07AAJCB8160E1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Bio Skylife is U52520DL2021PTC380495. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bio Skylife was incorporated on 22 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Bio Skylife by revenue are Innovations Mediresearch Private Limited, Ved Hospital Superspeciality & Medical Research Private Limited, Neshlin Medtech Private Limited, JDC Healthcare & Diagnostic Private Limited, Bharat Health & Wellness Private Limited and 5 more, all in the same principal business activity (human health activities).
Aman Singh Bhandari ceased to be Director on 23 Sep 2025. Mukeem Sabir was appointed as Director on 22 Sep 2025. Aman Singh Bhandari was appointed as Director on 16 Dec 2022. Bio Skylife has 5 board changes on record in total.
The registered office of Bio Skylife is at 1205 – D Mall Netaji Subhash Place, Delhi, India – 110034.
Bio Skylife operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Bio Skylife can be reached at its registered office: 1205 – D Mall Netaji Subhash Place, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
